Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva CEO Schultz: 'Proof Is In The Pudding' For US Biosimilars :: Generics Bulletin
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva CEO Vigodman steps down
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO Erez Vigodman Steps Down | CHEManager
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva CEO Erez Vigodman Resigns
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Erez Vigodman steps down as Teva CEO
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva's new CEO shakes up management, to combine divisions | Reuters
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva CEO: We have to launch new products - Globes
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
A Look At Kare Schultz, The New CEO In Charge Of Teva
